InsiderClue
Insiders · Profile

HILZINGER KURT J

Director at Outlook Therapeutics · President & COO at Cencora. Filing since 29 Jan 2007. CIK 0001191504

OTLK Outlook Therapeutics, Inc. Director · 37 trades COR Cencora President & COO · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK Outlook Therapeutics, Inc.
26 May 2026
Director
Bought
400,000
$176.52K
×17
OTLK Outlook Therapeutics, Inc.
5 Oct 2022
Director
Bought
15,662
$19.26K
3.4%
OTLK Outlook Therapeutics, Inc.
4 Oct 2022
Director
Bought
95,541
$123.25K
26.4%
OTLK Outlook Therapeutics, Inc.
3 Oct 2022
Director
Bought
41,798
$52.25K
13.1%
OTLK Outlook Therapeutics, Inc.
30 Sep 2022
Director
Bought
33,199
$41.83K
11.6%
OTLK Outlook Therapeutics, Inc.
29 Sep 2022
Director
Bought
13,800
$16.42K
5.1%
OTLK Outlook Therapeutics, Inc.
1 Mar 2022
Director
Bought
27,708
$46.83K
11.3%
OTLK Outlook Therapeutics, Inc.
28 Feb 2022
Director
Bought
6,000
$9.60K
2.5%
OTLK Outlook Therapeutics, Inc.
24 Feb 2022
Director
Bought
41,160
$60.09K
20.8%
OTLK Outlook Therapeutics, Inc.
23 Feb 2022
Director
Bought
79,535
$114.53K
67.0%
OTLK Outlook Therapeutics, Inc.
22 Feb 2022
Director
Bought
95,597
$142.44K
414%
OTLK Outlook Therapeutics, Inc.
4 Feb 2019
Director
Bought
5,983
$4.79K
3.3%
OTLK Outlook Therapeutics, Inc.
1 Feb 2019
Director
Bought
8,200
$6.31K
4.8%
OTLK Outlook Therapeutics, Inc.
31 Jan 2019
Director
Bought
6,300
$4.73K
3.8%
OTLK Outlook Therapeutics, Inc.
30 Jan 2019
Director
Bought
4,890
$3.52K
3.1%
OTLK Outlook Therapeutics, Inc.
29 Jan 2019
Director
Bought
5,400
$3.94K
3.5%
OTLK Outlook Therapeutics, Inc.
28 Jan 2019
Director
Bought
15,884
$11.28K
11.5%
OTLK Outlook Therapeutics, Inc.
25 Jan 2019
Director
Bought
10,828
$7.47K
8.5%
OTLK Outlook Therapeutics, Inc.
23 Jan 2019
Director
Bought
2,266
$1.52K
1.8%
OTLK Outlook Therapeutics, Inc.
22 Jan 2019
Director
Bought
10,749
$7.31K
9.4%
OTLK Outlook Therapeutics, Inc.
17 Jan 2019
Director
Bought
2,300
$1.59K
2.1%
OTLK Outlook Therapeutics, Inc.
16 Jan 2019
Director
Bought
800
$544.00
0.7%
OTLK Outlook Therapeutics, Inc.
15 Jan 2019
Director
Bought
2,266
$1.59K
2.1%
OTLK Outlook Therapeutics, Inc.
14 Jan 2019
Director
Bought
4,399
$3.12K
4.2%
OTLK Outlook Therapeutics, Inc.
10 Jan 2019
Director
Bought
6,053
$4.24K
6.1%
OTLK Outlook Therapeutics, Inc.
9 Jan 2019
Director
Bought
2,792
$2.04K
2.9%
OTLK Outlook Therapeutics, Inc.
8 Jan 2019
Director
Bought
6,410
$4.17K
7.2%
OTLK Outlook Therapeutics, Inc.
7 Jan 2019
Director
Bought
5,166
$3.25K
6.1%
OTLK Outlook Therapeutics, Inc.
4 Jan 2019
Director
Bought
6,205
$3.66K
7.9%
OTLK Outlook Therapeutics, Inc.
3 Jan 2019
Director
Bought
4,200
$2.48K
5.7%
OTLK Outlook Therapeutics, Inc.
2 Jan 2019
Director
Bought
1,640
$967.60
2.3%
OTLK Outlook Therapeutics, Inc.
31 Dec 2018
Director
Bought
11,349
$6.70K
18.6%
OTLK Outlook Therapeutics, Inc.
28 Dec 2018
Director
Bought
11,910
$6.19K
24.3%
OTLK Outlook Therapeutics, Inc.
27 Dec 2018
Director
Bought
730
$372.30
1.5%
OTLK Outlook Therapeutics, Inc.
26 Dec 2018
Director
Bought
5,714
$3.09K
13.4%
OTLK Outlook Therapeutics, Inc.
24 Dec 2018
Director
Bought
1,113
$734.58
2.7%
OTLK Outlook Therapeutics, Inc.
21 Dec 2018
Director
Bought
3,600
$2.34K
9.5%
COR Cencora
29 Jan 2007
President & COO
Sold, plan not stated
120,000
$6.21M
41.9%
38 decisions on file.